Navigation Links
Anti-obesity Drugs Claimed Additional Benefits on cardiometabolic Risk Factors Questioned

Additional beneficial effects on cardiometabolic risk factors beyond those expected from weight loss in trials of the anti-obesity drug rimonabant may not be due to the drug itself, reports an article in the June issue of Drug and Therapeutics Bulletin (DTB).

Advertisements for rimonabant (sold under the brand name Acomplia by Sanofi-Aventis) claim that an estimated 50% of the effects on cardiometabolic risk factors are beyond those expected from weight loss alone. But DTB argues that these effects are not proven to be due to the drug itself.

Also, no published trials have compared rimonabant with either of the other anti-obesity drugs orlistat or sibutramine. Instead, rimonobants effects on weight have been assessed in four double-blind trials comparing the drug with placebo.

The article says: In three of the trial reports, the authors state that the effects of rimonabant on HDL, triglycerides and HBA1c were partly independent of weight loss. However, it is not proven that any independent effect is wholly or partially attributable to rimonabant.

The article suggests that these observed effects might be related to increased activity based on the lifestyle advice given to participants at the start of the trials.

Furthermore, it is not known whether rimonabants effects on individual risk factors translate into a reduced long-term likelihood of cardiovascular events, the article adds.

. Rimonabant has not been directly compared with other, less expensive, drug treatments for obesity. Orlistat is the drug for obesity for which there is the most evidence for efficacy and safety to date, and we have previously concluded that it is a reasonable option for obese patients where diet and exercise and/or behavioural measures alone have failed.

Rimonabant is the most expensive of the anti-obesity drugs. A years treatment with rimonabant 20mg daily costs the NHS around 720, compar ed with 520 for orlistat 120 mg three times daily and 480-570 for sibutramine 10-15 mg daily.


Related medicine news :

1. Anti-obesity drugs for FDA approval
2. Canada Confronts Obesity Head-on, Anti-obesity Campaign on Fast Track
3. Lean Protein Could Be Key to Obesity Drugs
4. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
5. Nasal Spray Could Take Drugs Direct to Brain.
6. Emphasis to ban Drugs ads by Doctors
7. Osteoporosis Drugs: right time to take-off
8. Drugs disrupt formation of blood vessels
9. Drugs to stop burgeon of HIV
10. Misleading Advertisements for Prescription Drugs
11. Drugs For Anthrax May Interfere With Oral Contraceptives
Post Your Comments:

(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Revolutionary ... Oticon , industry leaders in advanced audiology ... of Oticon Opn ™, the world,s first internet ... possibilities for IoT devices.      (Photo: ... introduces a number of ,world firsts,: , ...
(Date:6/23/2016)... MEDIA, Pa. , June 23, 2016 ... treatments in an outpatient dialysis facility.  Treatments are usually ... to 6 hours per visit, including travel time, equipment ... on a patient, but especially grueling for patients who ... residents of a skilled nursing and rehabilitation centers for ...
(Date:6/23/2016)... June 23, 2016  Experian Health, the ... transforming the patient payment and care experience, ... new products and services that will enhance ... cycle offerings. These award-winning solutions will enable ... remain compliant in an ever-changing environment and ...
Breaking Medicine Technology: